Scrip
FDA: final guidance on developing cell-based viral vaccines
09 March 2010
Nancy Faigen
The
US FDA recognises emerging and pandemic threats – and it aims to boost the development of cell-based viral vaccines with the publication of a final guidance entitled
Guidance for Industry: Characterization and Qualification of Cell Substrates and Other Biological Materials Used in Production...
Please Login to read the full article.
09 March 2010
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
